NEA 17 GP, LLC's Net Worth

Estimate Recalculated Nov 11, 2024 01:51PM EST

Who is NEA 17 GP, LLC

NEA 17 GP, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Robinhood Markets, Inc., Monte Rosa Therapeutics, Inc., Savara Inc, NeueHealth, Inc., and Korro Bio, Inc..

SEC CIK

NEA 17 GP, LLC's CIK is 0001796821

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Robinhood Markets, Inc.

Investor

Updated May 04, 2022

View Quote Details


Form 4	-50.00%	-23.82M	—	—	May 04, 2022	23.82M	Disposition	—	May 02
Form 4	-33.37%	-23.87M	—	—	Feb 01, 2022	47.65M	Disposition	—	Jan 28
Form 4	-1.96%	-1.43M	—	—	Nov 12, 2021	71.51M	Disposition	—	Nov 10
Form 4	-1.92%	-1.43M	—	—	Oct 29, 2021	72.94M	Disposition	—	Oct 27
Form 4	—	—	$26.60	—	Aug 03, 2021	74.37M	Options	—	Aug 02
Form 3	—	—	—	—	Jul 29, 2021	2.51M	—	—	—

Showing 6 results

Monte Rosa Therapeutics, Inc.

Investor

Updated Jun 30, 2021

View Quote Details


Form 4	-67.20%	-15.76M	$19.00	—	Jun 30, 2021	7.69M	Buy-Options	—	Jun 28
Form 3	—	—	—	—	Jun 23, 2021	—	—	—	—

Showing 2 results

Savara Inc

Investor

Updated Jul 19, 2023

View Quote Details


Form 4	1.38%	333.33K	$3.00	$1.00M	Jul 19, 2023	24.47M	Purchase	—	Jul 17
Form 3	—	—	—	—	Mar 16, 2021	24.14M	—	—	—

Showing 2 results

NeueHealth, Inc.

Investor

Updated Apr 10, 2024

View Quote Details


Form 4	—	123.73K	—	—	Apr 10, 2024	123.73K	Purchase	—	Apr 08
Form 3/A	—	—	—	—	Oct 20, 2022	23.98M	—	—	—
Form 3	—	—	—	—	Oct 19, 2022	—	—	—	—

Showing 3 results

Korro Bio, Inc.

Investor

Updated Apr 24, 2024

View Quote Details


Form 4	1.66%	17.86K	$56.00	$999.99K	Apr 24, 2024	1.09M	Purchase	—	Apr 22
Form 3	—	—	—	—	Nov 07, 2023	1.07M	—	—	—

Showing 2 results

MBX Biosciences, Inc.

Investor

Updated Sep 17, 2024

View Quote Details


Form 4	-90.35%	-33.83M	$16.00	—	Sep 17, 2024	3.61M	Buy-Options	—	Sep 16
Form 3	—	—	—	—	Sep 12, 2024	—	—	—	—

Showing 2 results